Medtronic (NYSE:MDT – Free Report) had its price objective lifted by Wells Fargo & Company from $102.00 to $105.00 in a research note issued to investors on Friday, Benzinga reports. They currently have an overweight rating on the medical technology company’s stock. A number of other equities research analysts also recently issued reports on the […]